Conference program

Location: Hotel Suisse Majestic

Sunday, May 10th 2026 | Monday, May 11th 2026 | Tuesday, May 12th 2026

Sunday, May 10^th 2026

14:00 – 16:00	Pre-conference Workshop Future proofing your deals in a more volatile world Hannah England, Partner, Life Sciences Licensing & Collaborations Emily Oldshue, Partner, Life Sciences M&A at Ropes & Gray more information
15:30 onwards	Conference Registration / Check-In
16:00 - 17:00	Welcome Coffee & Networking
17:00 - 18:45	Welcome and opening of the Swiss HLG Conference 2026 Sarah Holland, President Swiss HLG Keynote Speakers Patrick Markus Aisher Chairman Kinled Holding Ltd Sameh Abadir Professor of Leadership and Negotiation
18:45 - 19:00	Ice-breaker Swiss HLG Board Members
19:00 - 21:00	Kick-off dinner
21:00 - onwards	Networking with peers

Monday, May 11^th 2026

07:00	Voluntary pre-conference morning run (meet at reception)
08:30 – 09:00	Swiss HLG General Assembly – members by invitation
09:00 - 09:05	Welcome
09:05 - 12:10	Intro: Europe – Strengthen stability, seize opportunities Markus Staempfli Vice President Europe Major Markets & Canada at CSL Behring Daniel Rankin SVP Head of Global Strategy and Corporate Development at Sobi - Swedish Orphan Biovitrum AB Dr. Marc Gitzinger Chief Executive Officer and co-founder of BioVersys Tim Dyer Founder, CEO/CFO and Board member at Addex Therapeutics
12:10 - 13:35	Lunch
13:35 - 16:55	Intro: The Tiger’s Speed, the Crane’s Vision: Forming Sustainable Alliances in Asia Leveraging “China Speed” to Enhance Pipelines and Accelerate Inflection Points for European Biopharmas Helen Chen, Greater China Managing Partner , Head of Asia Healthcare at L.E.K. Consulting The Great Realignment: Navigating Strategic Bifurcation and Ecosystem Activation in Japan’s Healthcare Sector Yue Feng, Vice President Investment Banking at Nomura International Plc Asia Rising, Europe Bridging Asia, Europe, and the Future of Global Biopharma during the Trump Tariff Era: From Fragmentation to Collaboration William Pay, Chief Investment & Strategy Advisor to the Chairman at HK WinHealth Pharma Group and Venture Partner, Pappas Capital Could the Chugai-Roche alliance model work in China? Lessons from a successful alliance for a new partnership landscape Ingo Stiller, Pharma Partnering, Head Chugai [Japan] & Basel Alliance Management at Roche
19:00	Swiss HLG networking dinner
21:45 - onwards	Networking with peers

Tuesday, May 12^th 2026

07:00	Voluntary pre-conference morning run (meet at reception)
09:00 - 09:05	Welcome
09:05 - 12:20	Intro: United States – Navigating Uncertainty and looking for Strategic Advantage Orlando Oliveira Chief Commercial Officer Zenas Biopharma From Idea to Value: Building Biotechs in a More Competitive World Katharina (Nina) Kreymborg, SVP (CSO Partner Team) at Curie.Bio Martin Slusarczyk Senior Director at Simon-Kucher Closing Key Note Some learning on Deal Making Sophie P. Kornowski, Chief Executive Officer at Sophiekor Insights
12:20 - 12:30	Closing remarks
12:30 - 13:30	Farewell Lunch & Networking